Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New IGF-I variant disclosed by P&U

Dec. 11, 1996

New neurotensin receptor ligands from Sanofi

Dec. 11, 1996

cGMP-PDE inhibitors revealed by Fujisawa

Dec. 11, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Antitumor borneol esters reported by Schering AG

Dec. 11, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Knoll claims potential anticonvulsants

Dec. 11, 1996

Pharma Mar describes cytotoxic xenicane diterpenes

Dec. 11, 1996

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...